Fu-Fang Ku-Shen Injection in Combination with Modern Medications in Treating Lymphoma: A Real-world Study Based on Association Rules And Apriori Algorithm
- VernacularTitle:复方苦参注射液治疗淋巴瘤联用西药特征:一项基于关联规则Apriori算法的真实世界研究
- Author:
Yinghui ZHANG
1
,
2
;
Yanming XIE
;
Yin ZHANG
;
Cen CHEN
;
Yan ZHUANG
Author Information
- Keywords: Fu-Fang Ku-Shen injection; lymphoma; real-world study; medication combinations; association rules
- From: World Science and Technology-Modernization of Traditional Chinese Medicine 2017;19(10):1648-1653
- CountryChina
- Language:Chinese
- Abstract: This study was aimed to investigate the application rrles of Fu-Fang Ku-Shen (FFKS) injection in combination with modern medicines for the treatment of lymphoma in the real world,in order to provide references for rational clinical application of effective medication.Patients diagnosed as lymphoma and treated with FFKS injection from 22 triple-A hospitals in China were enrolled as research objects.Patients' treatment data were extracted from the hospital information system,which was established by the Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,in order to analyze the frequency distribution characteristics of modern medications combined in the treatment.Association rules and Apriori algorithm were used in the analysis of association characteristics of medication combination.The results showed that 3 674 cases fit the inclusion criteria were searched from the data warehouse.In the clinical practice,FFKS injection was frequently combined with moderu medications,such as antibiotics,glucocorticoids,5-HT receptor antagonists,immunomodulatory drags,proton pump inhibitor,chemotherapeutic drugs,and hepatic protector.Its associated modern medication combination showed special rrles,which was in consistency with the related diagnosis and treatment of lymphoma guideline.It was concluded that FFKS injection combined with modern medicine in the treatment of lymphoma in the real world was basically in consistency with related guidelines.It was focused on reducing the side effects of chemotherapy,prolonging survival time,and improving quality of life.It provided references for rational clinical drag application of lymphoma.
